Skip Navigation


Carcinogenesis Advance Access originally published online on October 24, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
25/2/197    most recent
bgg196v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (24)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Estensen, R. D.
Right arrow Articles by Wattenberg, L. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Estensen, R. D.
Right arrow Articles by Wattenberg, L. W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 25, No. 2, 197-201, February 2004


MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION

Effect of chemopreventive agents on separate stages of progression of benzo[{alpha}]pyrene induced lung tumors in A/J mice

R. D. Estensen1,4, M. M. Jordan1, T. S. Wiedmann2, A. R. Galbraith1, V. E. Steele3 and L. W. Wattenberg1

1 Department of Laboratory Medicine and Pathology and 2 Department of Pharmaceutics, University of Minnesota, Minneapolis, MN 55455, USA and 3 Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892, USA

The effects of aerosol budesonide and dietary myo-inositol on progression of benzo[{alpha}]pyrene (B[{alpha}]P) induced carcinogenesis were studied in A/J mouse lung. First, we determined when to intervene in the carcinogenesis process by exposing several animals to B[{alpha}]P at 100 and 150 mg/kg of body wt. Groups of these animals were necropsied from 1 to 36 weeks post-carcinogen. The presence of different categories of lung tumors was noted over the 36 week time period. Hyperplasia first appeared ~6 weeks post-carcinogen followed by adenoma at 9 weeks, then by carcinoma at 26 weeks. From this temporal sequence we determined we could test for effects of preventive agents on progression to hyperplasia by intervening at 3 weeks, for effects on progression to adenoma by intervening at 6 weeks and for effects on progression to carcinoma by intervention at 12 weeks. Intervention at 3 weeks post-carcinogen with aerosolized budesonide delayed both hyperplasia and adenoma formation. Once hyperplasia appeared in budesonide treated animals, however, it increased at the same rate as in control animals, indicating a delay in progression. Progression from adenoma to carcinoma was reduced when budesonide was given 12 weeks post-carcinogen. Dietary myo-inositol failed to suppress progression from adenoma to carcinoma when started 12 weeks post-carcinogen. In summary, budesonide is a chemopreventive agent that has inhibitory effects on B[{alpha}]P induced carcinogenesis of the lung in A/J mice at all stages of progression from hyperplasia formation to cancer.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Prevention ResearchHome page
H. Fu, J. He, F. Mei, Q. Zhang, Y. Hara, S. Ryota, R. A. Lubet, R. Chen, D.-R. Chen, and M. You
Lung Cancer Inhibitory Effect of Epigallocatechin-3-Gallate Is Dependent on Its Presence in a Complex Mixture (Polyphenon E)
Cancer Prevention Research, June 1, 2009; 2(6): 531 - 537.
[Abstract] [Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
F. D'Agostini, L. Mastracci, A. Izzotti, R. Balansky, T. M. Pennisi, V. E. Steele, and S. De Flora
Modulation by Phenethyl Isothiocyanate and Budesonide of Molecular and Histopathologic Alterations Induced by Environmental Cigarette Smoke in Mice
Cancer Prevention Research, June 1, 2009; 2(6): 546 - 556.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
C. A. Dumstorf, S. Mukhopadhyay, E. Krishnan, B. Haribabu, and W. G. McGregor
REV1 Is Implicated in the Development of Carcinogen-Induced Lung Cancer
Mol. Cancer Res., February 1, 2009; 7(2): 247 - 254.
[Abstract] [Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
T. E. Johnson, F. Kassie, M. G. O'Sullivan, M. Negia, T. E. Hanson, P. Upadhyaya, P. P. Ruvolo, S. S. Hecht, and C. Xing
Chemopreventive Effect of Kava on 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone plus Benzo[a]pyrene-Induced Lung Tumorigenesis in A/J Mice
Cancer Prevention Research, November 1, 2008; 1(6): 430 - 438.
[Abstract] [Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
F. Kassie, I. Matise, M. Negia, D. Lahti, Y. Pan, R. Scherber, P. Upadhyaya, and S. S. Hecht
Combinations of N-Acetyl-S-(N-2-Phenethylthiocarbamoyl)-L-Cysteine and myo-Inositol Inhibit Tobacco Carcinogen-Induced Lung Adenocarcinoma in Mice
Cancer Prevention Research, September 1, 2008; 1(4): 285 - 297.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. W. Anderson, C. Goodin, Y. Zhang, S. Kim, R. D. Estensen, T. S. Wiedmann, P. Sekar, C. R. Buncher, J. C. Khoury, J. R. Garbow, et al.
Effect of dietary green tea extract and aerosolized difluoromethylornithine during lung tumor progression in A/J strain mice
Carcinogenesis, August 1, 2008; 29(8): 1594 - 1600.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. Parimon, J. W. Chien, C. L. Bryson, M. B. McDonell, E. M. Udris, and D. H. Au
Inhaled Corticosteroids and Risk of Lung Cancer among Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 712 - 719.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
F. S. Alyaqoub, L. Tao, P. M. Kramer, V. E. Steele, R. A. Lubet, W. T. Gunning, and M. A. Pereira
Prevention of mouse lung tumors and modulation of DNA methylation by combined treatment with budesonide and R115777 (ZarnestraMT)
Carcinogenesis, January 1, 2007; 28(1): 124 - 129.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
F. S. Alyaqoub, L. Tao, P. M. Kramer, V. E. Steele, R. A. Lubet, W. T. Gunning, and M. A. Pereira
Prevention of mouse lung tumors and modulation of DNA methylation by combined treatment with budesonide and R115777 (ZarnestraMT)
Carcinogenesis, December 1, 2006; 27(12): 2442 - 2447.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Balansky, F. D'Agostini, G. Ganchev, A. Izzotti, B. Di Marco, R. A. Lubet, N. Zanesi, C. M. Croce, and S. De Flora
Influence of FHIT on benzo[a]pyrene-induced tumors and alopecia in mice: Chemoprevention by budesonide and N-acetylcysteine
PNAS, May 16, 2006; 103(20): 7823 - 7828.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
S. S. Hecht
Deguelin as a Chemopreventive Agent in Mouse Lung Tumorigenesis Induced by Tobacco Smoke Carcinogens
J Natl Cancer Inst, November 16, 2005; 97(22): 1634 - 1635.
[Full Text] [PDF]


Home page
Cancer Res.Home page
C. C. Conaway, C.-X. Wang, B. Pittman, Y.-M. Yang, J. E. Schwartz, D. Tian, E. J. McIntee, S. S. Hecht, and F.-L. Chung
Phenethyl Isothiocyanate and Sulforaphane and their N-Acetylcysteine Conjugates Inhibit Malignant Progression of Lung Adenomas Induced by Tobacco Carcinogens in A/J Mice
Cancer Res., September 15, 2005; 65(18): 8548 - 8557.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
H. Witschi
Carcinogenic Activity of Cigarette Smoke Gas Phase and Its Modulation by Beta-Carotene and N-Acetylcysteine
Toxicol. Sci., March 1, 2005; 84(1): 81 - 87.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.